Scadden David sold AGIO
October 8, 2025 · Form 4 insider transaction
Scadden David sold 200 shares of Agios Pharmaceuticals, Inc. at $41.00 per share, a transaction worth $8.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$41.00
Total value
$8.2K
InsiderScadden David
Role—
SecurityCommon stock
Transaction codeS: Open-market sale
Transaction dateOctober 8, 2025
Filing dateOctober 10, 2025
Shares owned after17,603
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.